Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00888732
What this trial is testing

A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin

Who this might be right for
Diabetes Mellitus, Type 1
University of Aarhus 24
Post-approval studies (Phase 4)Study completedNCT00592969
What this trial is testing

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 164
Post-approval studies (Phase 4)Study completedNCT00393705
What this trial is testing

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 302
Post-approval studies (Phase 4)Study completedNCT01704378
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 89
Large-scale testing (Phase 3)Study completedNCT00280046
What this trial is testing

Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 307
Not applicableStudy completedNCT00842894
What this trial is testing

Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 3,421
Post-approval studies (Phase 4)Study completedNCT00461331
What this trial is testing

Comparison of Insulins Aspart and Lispro in Insulin Pumps

Who this might be right for
Type 1 Diabetes Mellitus
Tulane University Health Sciences Center 20
Early research (Phase 1)Study completedNCT00825253
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 24
Not applicableStudy completedNCT00657319
What this trial is testing

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 3,495
Early research (Phase 1)Study completedNCT03959514
What this trial is testing

AT247, NovoRapid® and Fiasp® in Glucose Clamp Study

Who this might be right for
Diabetes Mellitus, Type 1
Arecor Limited 18
Large-scale testing (Phase 3)Study completedNCT04460326
What this trial is testing

Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Treated With Insulin
Boston Medical Center 137
Large-scale testing (Phase 3)Study completedNCT03760068
What this trial is testing

Mylan Insulin Aspart Study

Who this might be right for
Diabetes Mellitus, Type 1
Mylan Inc. 478
Post-approval studies (Phase 4)Study completedNCT01123980
What this trial is testing

Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 521
Large-scale testing (Phase 3)Study completedNCT04079413
What this trial is testing

Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Geropharm 264
Large-scale testing (Phase 3)Study completedNCT00097877
What this trial is testing

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 293
Large-scale testing (Phase 3)Study completedNCT01445951
What this trial is testing

Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period

Who this might be right for
Type 1 Diabetes Mellitus
Mannkind Corporation 518
Not applicableStudy completedNCT01947556
What this trial is testing

Insulin by Jet-injection for Hyperglycemia in Diabetes

Who this might be right for
Diabetes Mellitus
University Medical Center Nijmegen 20
Post-approval studies (Phase 4)Study completedNCT00274274
What this trial is testing

Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 373
Large-scale testing (Phase 3)Study completedNCT01520818
What this trial is testing

Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 666
Post-approval studies (Phase 4)Study completedNCT01678235
What this trial is testing

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
Medical University of Warsaw 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation